WHC is still in active development. Read this to understand our approach.
depiction of MUCZHBLJLSDCSD-UHFFFAOYSA-N.svg
isomerdesign

Isoflurophate

Check on isomerdesign

pubchem

Diisopropyl fluoroph...

Check on pubchem

drugmap

Isoflurophate

Check on drugmap

Data

InChI: InChI=1S/C6H14FO3P/c1-5(2)9-11(7,8)10-6(3)4/h5-6H,1-4H3

Synonyms: GEO-01118,bis(propan-2-yl) fluorophosphate,TL 466,SCHEMBL63841, DIFP,Diisopropyl phosphorofluoridate,EINECS 200-247-6, Diisopropylfluorphosphorsaeureester,ZINC8214587, Phosphoric acid diisopropyl ester fluoride,D00043, Fluophosphoric acid, diisopropyl ester,Disiopropyl fluorophosphonate, 2-[fluoro(propan-2-yloxy)phosphoryl]oxypropane, Dipropan-2-yl phosphorofluoridoate,AKOS005258363,dipropan-2-yl phosphorofluoridoate,Diisopropyl fluoridophosphate #, Isoflurophate (USP),ISOFLUROPHATE [ORANGE BOOK],Diisopropylfluorfosfat [Czech],EN300-25090643,DIFP,Fluostigmine, DIISOPROPYL-FLUOROPHOSPHATE, Fluoropryl, Diisopropyl fluoridophosphate,Fluropryl,Fluorostigmine,Isoflurophate [USP],Isoflurophate,Isoflurophosphate,Fluoropryl, Isopropyl fluophosphate, Neoglaucit, Merck Brand of Isoflurophate, T-1703, Isofluorophate,MFCD00008873,DSSTox_GSID_40667,55-91-4,Phosphorofluoridic acid, bis(1-methylethyl) ester,PF-3,PDSP2_000464, Bis(propan-2-yl) fluorophosphate,Fluorodiisopropyl phosphate,bis(propan-2-yl) fluorophosphonate,NSC 727370,NCGC00168783-01,NSC-727370,ISOFLUROPHATE [WHO-DD],BDBM50022772, Di-isopropylphosphorofluoridate,Tox21_112643, Fluropryl,CHEBI:17941,diisopropyl fluorophosphate,DFP, O,O-Diisopropyl fluorophosphate,phosphorofluoridic acid diisopropyl ester, EA 1152,Neoglaucit,di-isopropyl fluorophosphate,Isofluorophate,RCRA waste no. P043, Floropryl (TN),Diisopropylfluorophosphate, >=97.0% (GC), Phosphorofluoridic acid, diisopropyl ester,DFP (pesticide),Diisopropylfluorphosphorsaeureester [German],Diisopropylphosphofluoridate,Floropryl (TN), Fluostigmine,Dyflos, Disiopropyl fluorophosphonate,Diisopropylfluorophosphate,BRN 1723307,CHEMBL1025,Fluorophosphoric acid, diisopropyl ester, Diflupyl,Isofluorphate,ISOFLUROPHATE [MI],12UHW9R67N, Isoflurophate [USP],O,O-Diisopropyl fluorophosphate,Rcra waste number P043,Diisopropyl fluorophosphonate, TL 466,T-1703,HSCI1_000366, Diisopropylfluorfosfat,Phosphorofluoridic acid, diisopropyl ester,Diisopropylfluorophosphoric acid ester, Fluorodiisopropyl phosphate, Diisopropylphosphorofluoridate,Diflupyl, Diisopropylfluorphosphorsaeureester [German],PDSP1_000466,ISOFLUROPHATE [USP IMPURITY],HSDB 2133,DB-052820, Diisopropyl fluorophosphonate,O,O'-Diisopropyl phosphoryl fluoride,Diisopropylphosphorofluoridate,2-[fluoro(propan-2-yloxy)phosphoryl]oxypropane,O,O''-Diisopropyl phosphoryl fluoride, Di isopropylphosphorofluoridate, Dyflos, Bis(1-methylethyl) Phosphorofluoridate,Isopropyl fluophosphate, PF-3, Diisopropoxyphosphoryl fluoride, Fluorophosphoric acid, diisopropyl ester,DSSTox_RID_79530,ISOFLUROPHATE [HSDB], Floropryl, Diisopropyl fluorophosphate, Diisopropylfluorophosphoric acid ester,Diisopropoxyphosphoryl fluoride,DB00677,Diisopropylfluorfosfat, Diisopropyl phosphorofluoridate, Diisopropylphosphofluoridate, Diisopropylfluorfosfat [Czech], Phosphorofluoridic acid, bis(1-methylethyl) ester, Isoflurophosphate,DSSTox_CID_20667,CAS-55-91-4,ISOFLUROPHATE [VANDF], Isofluorphate,Fluophosphoric acid, diisopropyl ester, Fluorostigmine,UNII-12UHW9R67N,Diisopropylfluorphosphorsaeureester, Diisopropylfluorophosphate,C00202,Diisopropyl fluoridophosphate, Diisopropyl phosphofluoridate, Diflurophate,Diisopropyl phosphofluoridate, Isopropyl phosphorofluoridate,Floropryl,Isopropyl phosphorofluoridate,Q384993,DTXSID1040667,EA 1152,DYFLOS [MART.],Diflurophate, O,O'-Diisopropyl phosphoryl fluoride


Estimated data

Solubility: -0.316 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 54.8% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.